Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 20.85% is in line with its 5-year average of 19.98%, near the high end of its 5-year range (0.73%–23.40%).
As of the fiscal period ended Tuesday, June 30, 2026. 28.32% above its 12-month average of 16.25%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 20.85%.
DEBT TO ASSETS RATIO
20.85%
DEBT TO ASSETS RATIO AVG TTM
16.25%
DEBT TO ASSETS RATIO AVG 3Y
19.73%
DEBT TO ASSETS RATIO AVG 5Y
19.98%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+28.32%
CURRENT VS 3Y AVG
+5.66%
CURRENT VS 5Y AVG
+4.37%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 448 covered companies
CURRENT VS SECTOR MEDIAN
+18853.32%
vs the sector median at left
Certara, Inc.
Market Cap
$1.57B
Debt to Assets Ratio
20.85%
TTM Avg
16.25%
3Y Avg
19.73%
5Y Avg
19.98%
Market Cap
$1.52B
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.65B
Debt to Assets Ratio
0.76%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.65B
Debt to Assets Ratio
0.22%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.45B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.43B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Certara, Inc. (CERT) | $1.57B | 20.85% | 16.25% | 19.73% | 19.98% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 0.25% | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.52B | 0.00% | N/A | N/A | N/A |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | 0.76% | N/A | N/A | N/A |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 0.22% | N/A | N/A | N/A |
| AnaptysBio, Inc. (ANAB)vs › | $1.46B | 0.85% | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 0.02% | N/A | N/A | N/A |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.43B | 0.00% | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 0.44% | N/A | N/A | N/A |
Debt/Assets
20.8%
Debt/Equity
0.30
Current Ratio
2.55
Interest Coverage
1.1x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 20.85% |
| 2026-03-31 | 20.01% |
| 2025-12-31 | 0.73% |
| 2025-09-30 | 19.70% |
| 2025-06-30 | 19.95% |
| 2025-03-31 | 19.52% |
| 2024-12-31 | 19.80% |
| 2024-09-30 | 19.86% |
| 2024-06-30 | 19.99% |
| 2024-03-31 | 19.61% |
| 2023-12-31 | 19.36% |
| 2023-09-30 | 19.87% |
| 2023-06-30 | 19.40% |
| 2023-03-31 | 19.57% |
| 2022-12-31 | 19.59% |
| 2022-09-30 | 20.24% |
| 2022-06-30 | 20.44% |
| 2022-03-31 | 20.49% |
| 2021-12-31 | 20.40% |
| 2021-09-30 | 20.89% |
| 2021-06-30 | 23.40% |
| 2021-03-31 | 23.67% |
| 2020-12-31 | 23.58% |
| 2020-09-30 | 37.23% |
| 2020-06-30 | 40.19% |
| 2019-12-31 | 38.70% |
